Clinical Trials · NCT02099084
Short Bowel Syndrome and Teduglutide Versus Placebo
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Mayo Clinic
- Enrollment
- 8
- Start date
- Jan 2014
- Locations
- 1 site, United States
- Primary endpoint
- Gastric Emptying Half-Time (T1/2)